Does not justify routine warfarin or aspirin in heart failure; leaves open optimal use pending large trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Keiji Yamamoto (2005) conducted a review in Heart failure and thrombosis. Antithrombotic therapy (warfarin, aspirin) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: